Showing 1 - 10 of 7,339
Persistent link: https://www.econbiz.de/10001256357
Persistent link: https://www.econbiz.de/10009550839
settling companies. In comparison, the rule of per se illegality entirely prevents collusion and the rule of reason induces …
Persistent link: https://www.econbiz.de/10009490191
Persistent link: https://www.econbiz.de/10010462784
There is a long-standing literature that recognizes that an efficient solution in correcting a consumption externality is through applying subsidies and taxes that line up private incentives with social ones. An equally long-standing literature tackles the appropriate methods of generating the...
Persistent link: https://www.econbiz.de/10013237532
Persistent link: https://www.econbiz.de/10013263401
Persistent link: https://www.econbiz.de/10012439514
There is a long-standing literature that recognizes that an efficient solution in correcting a consumption externality is through applying subsidies and taxes that line up private incentives with social ones. An equally long-standing literature tackles the appropriate methods of generating the...
Persistent link: https://www.econbiz.de/10012469100
We show how characterizing optimal patent policy for the pharmaceutical industry only requires information about generic producers' responses to changes in the effective duration and scope of new drug patents. To estimate these responses, we use data on Paragraph IV patent challenges, and two...
Persistent link: https://www.econbiz.de/10014097057
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...
Persistent link: https://www.econbiz.de/10013405463